Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2

Zhenghui Song(TCM-Intigrated Cancer Center of Southern Medical University), Aimin Li(Washington University in St. Louis)
Journal of Translational Medicine
April 5, 2022
Cited by 28


Related Papers